Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ICU MEDICAL INC/DEICUI · Entity 2385 | VP, GM-Infusion Capital | August 13, 2026 | August 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ICU MEDICAL INC/DE
Report date August 13, 2026 · Filed August 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,062 |
Reported balance
After 2026-08-13 transaction · row 1
1 source rowRow 1 · 2026-08-13 · Sale · Disposed 5,417 · Balance 17,062 F1: All shares sold were sold at the exact price disclosed. |
Filing footnotes · ownership attribution and instrument terms
F1: All shares sold were sold at the exact price disclosed.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 13, 2026 Filed Aug 13, 2026 22:56 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 5,417 | $181.33 | $982,264.61 |
DisclosureSEC source: 0001698998-26-000004 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,062 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| May 22, 2026 Filed May 22, 2026 19:47 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,123 | $132.21 | $280,684.80 |
DisclosureSEC source: 0001698998-26-000003 · primary_doc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,479 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.03 to $132.33, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:33 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 2,924 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-26-000002 · edgardoc.xml · derivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,924 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F3 · derivative.exercise_date: These PRSUs were granted on May 17, 2023. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 15 of the first, second, and third year following the year of grant. Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:33 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,295 | $125.85 | $162,975.75 |
DisclosureSEC source: 0001698998-26-000002 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,602 Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:33 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-26-000002 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 16,147 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-26-000001 · edgardoc.xml · derivative · entry 8 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,147 shares Expires 2027-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F7 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F1 · shares: Represents the settlement of performance stock units granted on 3/8/2024. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 250% of target, resulting in the acquisition of the shares reported herein. Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 2,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-26-000001 · edgardoc.xml · derivative · entry 7 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,908 Underlying: Common Stock · 2,153 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 630 | $132.00 | $83,160.00 |
DisclosureSEC source: 0001698998-26-000001 · edgardoc.xml · nonDerivative · entry 6 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,973 Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-26-000001 · edgardoc.xml · nonDerivative · entry 5 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These securities are Restricted Stock Units. Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 6,877 | $132.00 | $907,764.00 |
DisclosureSEC source: 0001698998-26-000001 · edgardoc.xml · nonDerivative · entry 4 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,450 Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 16,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-26-000001 · edgardoc.xml · nonDerivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the settlement of performance stock units granted on 3/8/2024. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 250% of target, resulting in the acquisition of the shares reported herein. Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 1,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-26-000001 · edgardoc.xml · derivative · entry 9 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,170 Underlying: Common Stock · 1,585 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F8 · derivative.exercise_date: One-third of the shares shall vest on each of the first, second, and third anniversaries of the grant date. The vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and thirty percent of the exercise price per share for thirty consecutive trading days. The appreciation must occur within four years from the grant date. F9 · derivative.expiration_date: Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. If earned, these PRSUs vest on the first, second, and third year following the year of grant. Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 702 | $132.00 | $92,664.00 |
DisclosureSEC source: 0001698998-26-000001 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,180 Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-26-000001 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2025 Filed Nov 25, 2025 20:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,897 | $152.35 | $441,364.32 |
DisclosureSEC source: 0001698998-25-000004 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,297 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 00:04 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 2,923 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-25-000002 · edgardoc.xml · derivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,924 Underlying: Common Stock · 2,923 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F3 · derivative.exercise_date: These PRSUs were granted on May 17, 2023. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 15 of the first, second, and third year following the year of grant. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 00:04 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,294 | $143.45 | $185,624.30 |
DisclosureSEC source: 0001698998-25-000002 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,194 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 00:04 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,923 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-25-000002 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 08, 2025 Filed Mar 10, 2025 23:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 2,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-25-000001 · edgardoc.xml · derivative · entry 7 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,061 Underlying: Common Stock · 2,153 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 08, 2025 Filed Mar 10, 2025 23:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 953 | $141.97 | $135,297.41 |
DisclosureSEC source: 0001698998-25-000001 · edgardoc.xml · nonDerivative · entry 4 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,565 Read SEC document |
| March 08, 2025 Filed Mar 10, 2025 23:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-25-000001 · edgardoc.xml · nonDerivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 23:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 4,755 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-25-000001 · edgardoc.xml · derivative · entry 6 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,214 Underlying: Common Stock · 4,755 shares Expires not disclosed F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 23:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 966 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-25-000001 · edgardoc.xml · derivative · entry 5 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 966 shares Expires 2025-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 23:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 467 | $141.97 | $66,299.99 |
DisclosureSEC source: 0001698998-25-000001 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,365 Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 23:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 966 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-25-000001 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| December 06, 2024 Filed Dec 6, 2024 21:43 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,241 | $156.25 | $350,158.49 |
DisclosureSEC source: 0001698998-24-000005 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,866 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| August 30, 2024 Filed Aug 30, 2024 21:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,502 | $163.22 | $408,370.19 |
DisclosureSEC source: 0001698998-24-000004 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,107 F1 · price: The sales price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.00 to $163.825, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 21:24 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 791 | $98.27 | $77,732.76 |
DisclosureSEC source: 0001698998-24-000002 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,980 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:49 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 2,923 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-24-000003 · edgardoc.xml · derivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,847 Underlying: Common Stock · 2,923 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F3 · derivative.exercise_date: One-third of the shares shall vest on each of the first, second, and third anniversaries of the grant date. The vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and thirty percent of the exercise price per share for thirty consecutive trading days. The appreciation must occur within four years from the grant date. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:49 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,294 | $98.08 | $126,915.52 |
DisclosureSEC source: 0001698998-24-000003 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,609 Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:49 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,923 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-24-000003 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 2,020 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-24-000001 · edgardoc.xml · derivative · entry 10 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,020 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F8 · derivative.exercise_date: These PRSUs were granted on March 8, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 6,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-24-000001 · edgardoc.xml · derivative · entry 8 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,459 Underlying: Common Stock · 6,459 shares Expires not disclosed F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 894 | $104.52 | $93,440.88 |
DisclosureSEC source: 0001698998-24-000001 · edgardoc.xml · nonDerivative · entry 6 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,771 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-24-000001 · edgardoc.xml · nonDerivative · entry 5 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 5,792 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-24-000001 · edgardoc.xml · derivative · entry 9 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,792 shares Expires 2024-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F7 · derivative.exercise_date: These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 966 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-24-000001 · edgardoc.xml · derivative · entry 7 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 966 Underlying: Common Stock · 966 shares Expires 2025-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 2,564 | $105.39 | $270,219.96 |
DisclosureSEC source: 0001698998-24-000001 · edgardoc.xml · nonDerivative · entry 4 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,645 Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 5,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-24-000001 · edgardoc.xml · nonDerivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 426 | $105.39 | $44,896.14 |
DisclosureSEC source: 0001698998-24-000001 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,417 Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 966 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-24-000001 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| December 01, 2023 Filed Dec 1, 2023 22:08 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 1,729 | $88.03 | $152,196.26 |
DisclosureSEC source: 0001698998-23-000003 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,877 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.96 to $88.125, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 08, 2023 Filed Mar 8, 2023 22:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 2,020 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-23-000002 · edgardoc.xml · derivative · entry 8 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,020 Underlying: Common Stock · 2,020 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F6 · derivative.exercise_date: These PRSUs were granted on March 8, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant. Read SEC document |
| March 08, 2023 Filed Mar 8, 2023 22:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 894 | $156.17 | $139,615.98 |
DisclosureSEC source: 0001698998-23-000002 · edgardoc.xml · nonDerivative · entry 6 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,606 Read SEC document |
| March 08, 2023 Filed Mar 8, 2023 22:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-23-000002 · edgardoc.xml · nonDerivative · entry 5 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 22:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 965 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-23-000002 · edgardoc.xml · derivative · entry 7 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,932 Underlying: Common Stock · 965 shares Expires 2025-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 22:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 428 | $157.47 | $67,397.16 |
DisclosureSEC source: 0001698998-23-000002 · edgardoc.xml · nonDerivative · entry 4 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,480 Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 22:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 965 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-23-000002 · edgardoc.xml · nonDerivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 22:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 1,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-23-000002 · edgardoc.xml · derivative · entry 9 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,417 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F7 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F8 · derivative.exercise_date: These PRSUs were granted on March 6, 2020. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 22:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 626 | $161.25 | $100,942.50 |
DisclosureSEC source: 0001698998-23-000002 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,943 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.